Alan Brochstein, CFA
Contrarian, growth at reasonable price, management change, cannabis stocks

3 Reasons Investors Are Yawning At RTI Biologics' Transformational Deal

RTI Biologics (NASDAQ:RTIX), based in Florida, has a checkered history in the medical device space as a provider of natural tissues and technologies used in a variety of orthopedic and other surgical procedures. The company announced what is clearly a potentially transformational acquisition of privately-held Pioneer Surgical Technology on June 12th, but the market barely responded. While this could be a game-changer for RTIX if the deal achieves the primary goals of diversifying the product portfolio and customer base while raising margins and growth, there are several reasons that investors will not rush in to buy the story.

Background

RTIX was formed in 1997 as a subsidiary of the University of Florida Tissue Bank, began operations in 1998...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details